Pathogenetic approach to therapy of peripheral corneal inflammatory disease.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000468:Alkalies; D002648:Child; D002701:Chloramphenicol / Q000627:therapeutic use; D003091:Colistin / Q000627:therapeutic use; D003315:Cornea; D003320:Corneal Ulcer / Q000188:drug therapy; D005126:Eye Burns / Q000188:drug therapy; D005128:Eye Diseases / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007634:Keratitis / Q000139:chemically induced / Q000188:drug therapy; D007635:Keratitis, Dendritic / Q000188:drug therapy; D007637:Keratoconjunctivitis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011113:Polymyxins / Q000627:therapeutic use; D011183:Postoperative Complications; D012163:Retinal Detachment / Q000188:drug therapy
D000468:Alkalies; D011113:Polymyxins; D002701:Chloramphenicol; D006493:Heparin; D003091:Colistin